During the October 6 episode of Mad Money, Jim Cramer examined whether CVS Health Corporation’s (NYSE:CVS) turnaround still ...

Colossal Biosciences expands its de-extinction platform, linking synthetic biology to conservation, genome engineering, and future healthcare applications.

On October 9th, 2026, private growth equity firm Sopris Capital finalised the acquisition of medical imaging artificial ...

The Project Healthy Minds Workforce Lab, a first of its kind coalition of employers and Harvard Business School, is tackling ...

Israeli leader Benjamin Netanyahu has described the film, which got a standing ovation at the Venice Film Festival, as part ...

Concerns have been raised after several patients were reportedly unable to obtain their prescribed medication at various ...

The trades put some of Ark's better-known holdings on the sell side, including AMD, Alphabet, and SpaceX, while its genomics-focused ARK Genomic Revolution ETF continued to add to biotech companies.

Spread the love“`html When you entrust your health information to a hospital, you expect it to be safeguarded with the utmost ...

Jeffrey DeMarco, Senior Technical Advisor for Protecting Children from Digital Harm at Save the Children, shares seven tips for children, families and tech companies to support safer online ...

UK households shift more budget to recurring subscriptions, with health tech and pet food seeing the fastest growth in ...

CBS Sunday Morning Correspondent and technology and science writer David Pogue was the featured speaker at Fort Wayne’s 51st ...

AlphaFold, an AI program through Google Deepmind, recently mapped the structures of all 200 million known proteins, swinging ...